About Transcatheter Aortic Valves Transcatheter aortic valves are prosthetic heart valves used for the replacement of diseased aortic valves in the heart. Disorders of aortic valve include aortic stenosis, regurgitation, and degeneration. The procedure for aortic valve replacement with transcatheter aortic valves involves the implantation of prosthetic aortic valve using a catheter without incisions and without the need for cardioplegia. The catheterization for valve insertion can be done in femoral artery (transfemoral approach) or through a small chest incision between the ribs (transapical approach). TechNavio's analysts forecast the Transcatheter Aortic Valves market in the US to grow at a CAGR of 25.39 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Transcatheter Aortic Valves market in the US for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valves used in transcatheter aortic valve replacement procedures in the US. TechNavio's report, the Transcatheter Aortic Valves market in the US 2014-2018, has... Research Beam Model: Research Beam Product ID: 150114 2500 USD New
Transcatheter Aortic Valves Market in the US 2014-2018
 
 

Transcatheter Aortic Valves Market in the US 2014-2018

  • Category : Medical Devices
  • Published On : November   2014
  • Pages : 61
  • Publisher : Technavio
 
 
 
About Transcatheter Aortic Valves
Transcatheter aortic valves are prosthetic heart valves used for the replacement of diseased aortic valves in the heart. Disorders of aortic valve include aortic stenosis, regurgitation, and degeneration. The procedure for aortic valve replacement with transcatheter aortic valves involves the implantation of prosthetic aortic valve using a catheter without incisions and without the need for cardioplegia. The catheterization for valve insertion can be done in femoral artery (transfemoral approach) or through a small chest incision between the ribs (transapical approach).

TechNavio's analysts forecast the Transcatheter Aortic Valves market in the US to grow at a CAGR of 25.39 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Transcatheter Aortic Valves market in the US for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valves used in transcatheter aortic valve replacement procedures in the US.
TechNavio's report, the Transcatheter Aortic Valves market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Transcatheter Aortic Valves market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Vendors
• Boston Scientific
• Edwards LifeSciences
• Medtronic
• St. Jude Medical
Other Prominent Vendors
• Direct Flow Medical
• Sorin
Market Driver
• Increased Aging Population
• For a full, detailed list, view our report
Market Challenge
• Presence of Alternative Procedures
• For a full, detailed list, view our report
Market Trend
• Revised Labeling of Sapien Transcatheter Heart Valve
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Buying Criteria
08. Regulatory Environment
09. Pipeline Products
09.1 Key Information for Pipeline Products
09.1.1 TranScatheter Aortic Valve RepLacement System
09.1.2 Portico Re-sheathable Transcatheter Aortic Valve System
09.1.3 Lotus Valve System
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.2 Vendor Analysis 2013
16.2.1 Product Portfolio Matrix
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Boston Scientific
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation
17.1.4 Business Strategy
17.1.5 Business Segmentation by Revenue
17.1.6 Business Segmentation by Revenue 2012 and 2013
17.1.7 Geographical Segmentation by Revenue
17.1.8 Key Developments
17.1.9 SWOT Analysis
17.2 Edward Lifesciences
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2013
17.2.4 Business Segmentation by Revenue 2012 and 2013
17.2.5 Geographical Segmentation by Revenue 2013
17.2.6 Business Strategy
17.2.7 Recent Information
17.2.8 SWOT Analysis
17.3 Medtronic
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation by Revenue 2013
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Geographical Segmentation by Revenue 2013
17.3.6 Business Strategy
17.3.7 Recent Developments
17.3.8 SWOT Analysis
17.4 St. Jude Medical
17.4.1 Key Facts
17.4.2 Business Description
17.4.3 Business Segmentation
17.4.4 Business Strategy
17.4.5 Business Segmentation by Revenue
17.4.6 Geographical Segmentation by Revenue
17.4.7 Key Information
17.4.8 SWOT Analysis
18. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Transcatheter Aortic Valves Market in US 2013-2018 (US$ million)
Exhibit 3: Pipeline Snapshot of Transcatheter Aortic Valves in US
Exhibit 4: Boston Scientific: Business Segmentation 2013
Exhibit 5: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 6: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 7: Boston Scientific: Geographical Segmentation by Revenue 2012 and 2013 2013
Exhibit 8: Edwards Lifesciences: Business Segmentation by Revenue 2013
Exhibit 9: Edwards Lifesciences: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 10: Edwards Lifesciences: Geographical Segmentation by Revenue 2013
Exhibit 11: Medtronic: Business Segmentation by Revenue 2013
Exhibit 12: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 13: Medtronic: Geographical Segmentation by Revenue 2013
Exhibit 14: St. Jude Medical: Business Segmentation
Exhibit 15: St. Jude Medical: Business Segmentation by Revenue 2013
Exhibit 16: St. Jude Medical: Geographical Segmentation by Revenue 2012



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT